Drug recall · January 24, 2024
Vasostrict recall
Why: Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10
- Lots / codes
Lot # 66702; Exp. 02/2025
- Quantity
- 1721 cartons
- Company
- Par Sterile Products LLC, Rochester, MI
- Distribution
- Nationwide USA
- Initiated
- January 11, 2024 · Voluntary: Firm initiated
- Classified
- January 16, 2024
- Reported
- January 24, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.